News

BioSpace1h
Pfizer’s $6B China Deal, Drug Pricing and FDA’s New COVID Vaccine Plan
China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most Favored Nation executive order; FDA Commissioner Marty Makary and CBER director ...
The Daily News6h
Vaccine policy limits access to COVID shots
The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk ...
McKnight's Long-Term Care News9h
Older adults gain new COVID vaccine option as FDA approves protein-based shot
The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...
FDA tightens requirements for COVID vaccine, adding trials for healthy adults
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...
The FDA is making it more difficult for Americans to get vaccinated for covid
In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...
Report: U.S. young men feel lonelier than other age groups
About a fourth of younger men surveyed in the United States feel lonely, which is significantly higher than the national ...
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
MedPage Today14h
FDA Panel to Consider COVID Vaccine Makeup for Next Season
The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...
Healthy Returns: Novavax scores narrower Covid vaccine approval after delay
Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...